Ligand Pharmaceuticals | LGND - Pre Tax Profit

Stock Price
190.44
Daily Change
-1.25 -0.65%
Monthly
-4.76%
Yearly
65.33%
Q1 Forecast
186.18

Ligand Pharmaceuticals reported $141.14M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Amgen USD 3.92B 2.35B Sep/2025
Arrowhead Research USD 28.27M 7.85M Dec/2025
Baxter International USD 121M 12M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Gilead Sciences USD 2.43B 780M Jun/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Glaxosmithkline GBP 2.46B 569M Sep/2025
Insmed USD -368.7M 48.26M Sep/2025
Ionis Pharmaceuticals USD -129M 253M Sep/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Merck USD 6.74B 22M Sep/2025
Pacira USD -1.93M 10.63M Jun/2025
Pfizer USD 3.33B 290M Sep/2025
Veracyte USD 18.89M 17.64M Sep/2025